The OraQuick Advance Rapid HIV-112 Antibody Test, from OraSure, is comparable in accuracy to the traditional blood test, according to...
Sorrento Therapeutics, Inc. announced that it has received an official CE Mark for Covistix and a Registration Number: BE/CA01/1-17633-00001-IVD.
OraSure Technologies has received an FDA Emergency Use Authorization (EUA) for its OraQuick Ebola Rapid Antigen Test for use with...
Verify Diagnostics announced that Health Canada has authorized the Assure Tech Ecotest COVID-19 serological rapid test to be used at the point-of-care (POC) for the purpose of screening for SARS-CoV-2 antibodies.
Milestone Pharmaceuticals Inc. announced positive topline efficacy and safety data from the Phase III RAPID clinical trial of etripamil, the Company's investigational calcium channel blocker, in patients with paroxysmal supraventricular tachycardia (PSVT)
Readouts from two phase III clinical trials demonstrated that Eli Lilly and Company's Ultra Rapid Lispro (URLi) met the primary...
Allergan Aesthetics, an AbbVie company and Soliton announced a definitive agreement under which Allergan Aesthetics will acquire Soliton and Resonic, its Rapid Acoustic Pulse device which recently received FDA 510(k) clearance and is a non-invasive treatment for the short-term improvement in the appearance of cellulite.
Sorrento Therapeutics, Inc. announced that initial testing of COVISTIX on recombinant N proteins demonstrated its ability to detect the Omicron variant, in addition to detecting the original SARS-CoV-2 virus and its other major VoCs such as the delta and delta-plus strains.
The EU Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing...